ARCHIVES

Hagop Kantarjian: Why Drugs Cost Too Much and How Prices Can be Brought Down

This article is from The Cancer Letter archive.

Vol. 39 No. 22 | May 31, 2013

Download PDF Visit The Full Archive

Related Articles

NCI Unconventional Innovations Program releases Broad Agency Announcement.

October 24, 2003

CPRIT Executive Director Bill Gimson Is Out As Scandal Grows, Investigations Begin

December 14, 2012

NIH On R29 Phase-Out; Grant Review Appeals Process Changed

January 23, 1998

DeVita Says He Did Not Agree To Include “Chop-Like” Elements In CCOP RFA But That He Would Consider It

March 19, 1982

New Agent Targets Glioma Tumor Cells Prior To Surgery

May 30, 2003

HPV Vaccines Should Be Priority, Say President’s Cancer Panel

March 7, 2014